Skip to main content

Table 1 Clinicopathological characteristics of the patients

From: Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2

Feature

Number of patients (%)

Patients enrolled

156

Age (years):

 

<40

12 (8)

40–60

85 (54)

>60

59 (38)

Histology type:

 

Ductal

109 (70)

Lobular

17 (11)

Other

30 (19)

Tumour size:

 

T1

49 (31)

T2

90 (58)

T3-T4

17 (11)

Lymph-node status

 

Node negative

66 (42)

Node positive

90 (58)

Histopathological grade

 

I + II

57 (37)

III

86 (55)

Not analyzed

13 (8)

Oestrogen receptor

 

Positive (>20 fmol/mg)

116 (74)

Negative (≤ 20 fmol/mg)

40 (26)

Progesterone receptor

 

Positive (>20 fmol/mg)

85 (54)

Negative (≤ 20 fmol/mg)

71 (46)